We're just back from our National Cardiovascular Data Summit held in Canberra last Friday 27 June.Cardiovascular disease is still the leading cause of mortality in Australia and we see data playing an integral role in improving patient outcomes.

ACvA Board Director Professor Natasha Lannin’s path to becoming a clinician researcher in stroke rehabilitation wasn’t a straight line. Originally studying architecture, her life changed when a family member was involved in a serious accident.

Dr. Julee McDonagh’s career journey from nursing to research has always been driven by a desire to improve clinical practice and patient outcomes. Like many researchers, her direction has been shaped by chance encounters, sideways roles and inspirational colleagues.

Approximately 50% of adults living with Heart Failure are classified as frail, resulting in poorer health outcomes, higher hospitalisations, and increased mortality rates.

Australia’s visionary cardiovascular and stroke researchers were honoured last night at the annual Australian Cardiovascular Alliance (ACvA) Excellence in Cardiovascular Research Awards.

The Australian Cardiovascular Alliance (ACvA) is delighted to announce the appointment of Rob Tassie as Chief Executive Officer, commencing 3 February 2025.

The inaugural National Hypertension Summit 2024 was held last Tuesday November 26 in Sydney.

The 2024 National Cardiovascular Early and Mid-Career Researchers (EMCR) Summit, held in Sydney yesterday was a fantastic opportunity to connect, learn, and grow alongside peers, mentors, and experts in the field.

Recommendations from the 2023 National Cardiovascular Workforce Sustainability Summit have been released highlighting current challenges in career progression and retention in cardiovascular research.

The Australian Cardiovascular Alliance (ACvA) has received vital Federal funding to advance its innovative national approach addressing cardiovascular disease (CVD) and stroke. The Australian Government funding will bolster ACvA’s work to align research with health system priorities and facilitate multi-stakeholder collaborations.

Cardiovascular disease (CVD) remains a leading cause of death and disability in Australia. While this burden can seem overwhelming, the nation’s cardiovascular leaders believe that with improved coordination and pathways for prioritised translation our talented researchers can make substantial impacts on prevention, early disease detection and treatment.

We’ve just returned from the Asia Pacific Heart Summit in Bangkok, where it was both humbling and inspiring to engage with so many passionate cardiovascular disease (CVD) advocates from across the region.

On Wednesday, 25 September, the ACvA Arrhythmia Clinical Theme gathered in Sydney for a face-to-face Atrial Fibrillation workshop bringing together clinicians, researchers and consumers to explore key areas in atrial fibrillation (AF) research and management.

On September 5th, a landmark workshop at the University of Wollongong’s Innovation Campus brought together an influential group of doctors, researchers, patients, and health leaders from across Australia to address the widening disparities in heart and stroke health outcomes between rural and urban communities.

National multidisciplinary collaboration is vital for advancing cardiovascular research and care. By breaking down silos and incorporating diverse perspectives, particularly those of patients, researchers can ensure their work has a meaningful impact on improving patient outcomes and quality of life.

17 May is World Hypertension Day, and the National Hypertension Taskforce urges everyone to prioritise their health by getting their blood pressure checked.

Mentorship has long been a cornerstone of professional growth, whether through formal programs or the natural mentorship that occurs when working closely with others. It provides vital support, fosters meaningful connections, and leaves a lasting impact on both the mentor and mentee.

Last week, we launched the National Hypertension Taskforce Roadmap at Parliament House in Canberra, where we had the privilege of hearing powerful stories from individuals whose lives have been impacted by high blood pressure.

Last Monday, on the 18th of March, we had the privilege of launching the National Hypertension Taskforce Roadmap at Parliament House in Canberra.

High blood pressure, also known as hypertension, stands as the foremost risk factor for Australia’s top three killers: coronary heart disease, stroke, and dementia. Despite this, Australia lags behind nations like Germany, Canada, and the US in blood pressure control rates.

Last month we celebrated our annual ACvA Excellence in Cardiovascular Awards at the Victorian Heart Hospital in Melbourne.

Australia’s world-class cardiovascular and stroke researchers were honoured last night at the Australian Cardiovascular Alliance (ACvA) Excellence in Cardiovascular Research Awards.

The National EMCR Summit held on Wednesday 2 August was a joint initiative of the Australian Cardiovascular Alliance, Cardiac Society of Australia and New Zealand and the National Heart Foundation. It was great to have medical research institutes, peak bodies and cardiovascular research networks all in the room and ready to discuss career sustainability in the CVD & stroke sector.

High blood pressure (hypertension) is the leading risk factor for death in Australia and globally. In Australia, raised blood pressure is responsible for 43% of coronary heart disease, 41% of stroke, 38% of chronic kidney disease and 32% of atrial fibrillation and flutter.

One in three Australian adults have high blood pressure (also known as hypertension) which is the leading risk factor for Australia’s top three killers; coronary heart disease, stroke and dementia.